← Leaderboards
James E Udelson
Tufts Medical Center
$1,950,660
Attributed
$1,950,660
Total exposure
6
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $797.3K · FY2005–08$1M$750K$500K$250K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$4,068,173 · 7
By mechanism
R01$2,117,513 · 3
P50$1,739,988 · 1
U01$205,913 · 1
M01$4,759 · 2
Top collaborators
No co-investigators on record.
Most similar at Tufts Medical Center
Same institution · by research overlap
- Paul M Hassoun$13,983,399
- Athan Kuliopulos$25,203,288
- Iris Z Jaffe$20,757,672
- Joachim H Ix$16,690,262
- Barry L Fanburg$7,077,961
Others in their field
Top investigators on “Myocardial Infarction”
- Judith S Hochman · New York University School Of Medicine$121,330,744
- Paul M. Ridker · Brigham And Women'S Hospital$57,742,470
- Gervasio A Lamas · Mount Sinai Medical Center (Miami Beach)$57,397,502
- Pamela Susan Douglas · Duke University$51,876,470
- Julie E Buring · Brigham And Women'S Hospital$46,647,558
- Walter N Kernan · Yale University$42,197,025
Research focus
Myocardial InfarctionClinical ResearchHuman SubjectHormone Regulation /Control MechanismHuman Therapy EvaluationPostmenopauseFemaleCardiovascular FunctionEstrogensEstrogen ReceptorsClinical TrialsMyocardial Ischemia /HypoxiaHeart VentricleArrhythmiaHeart ContractionOsteoporosisGenetic MarkersChemopreventionGenetic PolymorphismBaroreceptorsEstrogen InhibitorAutonomic ReflexCardiovascular Disorder ChemotherapyGenotype
Grant awards (21)
Myocardial Viability and Remodeling in the OAT$140,070
R01 · FY2008 · HL · contact PI
Myocardial Viability and Remodeling in the OAT$188,457
R01 · FY2007 · HL · contact PI
Myocardial Viability and Remodeling in the OAT$515,980
R01 · FY2006 · HL · contact PI
Myocardial Viability and Remodeling in the OAT$190,327
R01 · FY2006 · HL · contact PI
LV Function Assessment Core Lab for IMMEDIATE Trial$90,975
U01 · FY2006 · HL · contact PI
Myocardial Viability and Remodeling in the OAT$540,654
R01 · FY2005 · HL
LV Function Assessment Core Lab for IMMEDIATE Trial$94,082
U01 · FY2005 · HL
SELECTIVE ESTROGEN RECEPTOR MODULATION: EFFECTS IN POST-MENOPAUSAL WOMEN$603
M01 · FY2005 · RR
Foreign Cohort: Myocardial Viability and Remodeling in the OAT-NUC$0
R01 · FY2005 · HL
Domestic Cohort: Myocardial Viability and Remodeling in the OAT-NUC$0
R01 · FY2005 · HL
Myocardial Viability and Remodeling in the OAT$542,025
R01 · FY2004 · HL
ESTROGEN RECEPTOR MODULATION--EFFECTS IN POST MENOPAUSAL WOMEN$230,991
P50 · FY2004 · HL
LV Function Assessment Core Lab for IMMEDIATE Trial$20,856
U01 · FY2004 · HL
Selective Estrogen Receptor Modulation: Effects in Women$4,156
M01 · FY2004 · RR
ESTROGEN RECEPTOR MODULATION--EFFECTS IN POST MENOPAUSAL WOMEN$228,923
P50 · FY2003 · HL
ESTROGEN RECEPTOR MODULATION--EFFECTS IN POST MENOPAUSAL WOMEN$442,783
P50 · FY2002 · HL
Estrogen receptor modulation--Effects in postmenopausal women following myocardia$0
M01 · FY2002 · RR
ESTROGEN RECEPTOR MODULATION--EFFECTS IN POST MENOPAUSAL WOMEN$439,023
P50 · FY2001 · HL
Estrogen receptor modulation--Effects in postmenopausal women following myocardia$0
M01 · FY2001 · RR
ESTROGEN RECEPTOR MODULATION--EFFECTS IN POST MENOPAUSAL WOMEN$398,268
P50 · FY2000 · HL
Estrogen receptor modulation--Effects in postmenopausal women following myocardia$0
M01 · FY2000 · RR